Perspectives on Outsourcing

Apr 01, 2012
BioPharm International
By BioPharm International Editors
Recovery audits and other best practices in procurement can improve the bottom line.
Mar 01, 2012
BioPharm International
The evolving bio/pharmaceutical business model poses risk for CMOs.
Feb 01, 2012
BioPharm International
By BioPharm International Editors
Industry optimism is on the rise for 2012.
Jan 01, 2012
BioPharm International
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
Oct 01, 2011
BioPharm International
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Sep 01, 2011
BioPharm International
The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
Aug 01, 2011
BioPharm International
China rises to the top as a destination for international outsourcing.
Jul 01, 2011
BioPharm International
By BioPharm International Editors
Better strategies and practices in sourcing and procurement can contribute to the bottom line.
Jun 01, 2011
BioPharm International
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
May 01, 2011
BioPharm International
Addressing supply-chain challenges.
native1_300x100
lorem ipsum